The R&D Scenario in the Indian Pharmaceutical Industry
Reji K. Joseph
Research and Information System for Developing Countries
February 22, 2012
RIS Discussion Paper No. 176
A set of policy reforms were introduced in the Indian pharmaceutical sector since mid 1990s aimed at incentivizing the private sector R&D. Patent reforms was the most significant policy reform. An implicit assumption that the Indian pharmaceutical firms have become capable of developing new drugs underlined these reforms and it was expected that both the Indian firms and MNCs would invest in R&D on new drugs not only for diseases that are prevalent globally but also for diseases that are specific to India and other tropical countries. This discussion paper provides an analysis of the impact of these reforms on pharmaceutical R&D in India. It looks into the context in which the reforms were introduced, the nature and trends of R&D efforts and emerging R&D strategies.
Number of Pages in PDF File: 57
Keywords: Indian pharmaceutical industry, R&D, policy reforms, patents, neglected diseases
JEL Classification: F14, L65, O38working papers series
Date posted: May 1, 2012
© 2013 Social Science Electronic Publishing, Inc. All Rights Reserved.
This page was processed by apollo8 in 0.281 seconds